Sunday, March 29, 2020

Strides Pharma Science receives EIR for Bengaluru facility from USFDA

Strides Pharma Science receives EIR for Bengaluru facility from USFDA The inspection by the US Food and Drug Administration (USFDA) was related to specific extended release applications made from the site. Receipt of EIR confirms the successful closure of the inspections, Strides Pharma Science said in a regulatory filing.

from Moneycontrol Business News https://ift.tt/3azrdms
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

A 'non-event Budget' for stock market: Is that good news for Nifty which fell 1,000 points in January?

As Budget 2026 approaches, analysts expect a low-impact event for equities amid muted expectations. With Nifty already down sharply in Janua...